Covered recipient · General Payments record
CURTIS GLIDEWELL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,473.94
- Reported across 105 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $383.43 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $256.19 | 19 |
| Abbott Laboratories | $41.89 | 2 |
| GlaxoSmithKline, LLC. | $28.32 | 2 |
| Sumitomo Pharma America, Inc. | $20.98 | 1 |
| Lilly USA, LLC | $18.93 | 1 |
| Amgen Inc. | $17.12 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.88 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125171753 | CMS |
| Abbott Laboratories | $21.01 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125171755 | CMS |
| ABBVIE INC. | $24.54 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804580 | CMS |
| ABBVIE INC. | $19.64 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804582 | CMS |
| ABBVIE INC. | $7.52 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804584 | CMS |
| ABBVIE INC. | $4.46 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804586 | CMS |
| ABBVIE INC. | $15.09 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804588 | CMS |
| ABBVIE INC. | $20.14 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804590 | CMS |
| ABBVIE INC. | $11.03 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804592 | CMS |
| ABBVIE INC. | $12.20 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804594 | CMS |
| ABBVIE INC. | $19.22 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804596 | CMS |
| ABBVIE INC. | $33.52 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804598 | CMS |
| ABBVIE INC. | $8.73 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804600 | CMS |
| ABBVIE INC. | $10.60 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804602 | CMS |
| ABBVIE INC. | $5.04 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804604 | CMS |
| ABBVIE INC. | $8.68 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804606 | CMS |
| ABBVIE INC. | $7.75 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804608 | CMS |
| ABBVIE INC. | $5.23 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804610 | CMS |
| ABBVIE INC. | $16.35 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804612 | CMS |
| ABBVIE INC. | $19.27 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804614 | CMS |
| ABBVIE INC. | $7.18 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103804616 | CMS |
| Amgen Inc. | $17.12 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117261627 | CMS |
| GlaxoSmithKline, LLC. | $14.16 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115982852 | CMS |
| GlaxoSmithKline, LLC. | $14.16 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116438333 | CMS |
| Lilly USA, LLC | $18.93 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136125949 | CMS |
| Sumitomo Pharma America, Inc. | $20.98 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148856629 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.